Investor Blatt Lawrence
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Blatt Lawrence . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-03-12 13D/A ALGS / Aligos Therapeutics, Inc. 3,888,253 175,509
2023-11-06 13D ALGS / Aligos Therapeutics, Inc. 2,677,970 3,888,253
2023-02-08 13G/A ALGS / Aligos Therapeutics, Inc. 2,509,377 2,677,970
2022-02-10 13G/A ALGS / Aligos Therapeutics, Inc. 2,396,877 2,509,377
2021-02-11 13G ALGS / Aligos Therapeutics, Inc. 2,396,877